BioAdvance Announces Seed-Stage Investment in Novira Therapeutics to Advance Antiviral Drug Discovery

Published: Mar 30, 2009

PHILADELPHIA--(BUSINESS WIRE)--BioAdvance, the Biotechnology Greenhouse Corporation of Southeastern Pennsylvania, today announced a $550,000 seed-stage investment in Novira Therapeutics, Inc., an emerging life sciences company in Southeastern Pennsylvania.

Back to news